Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore.
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use through 2 phases: 1) Phase 1 = process outcomes evaluation with 30 patients); and 2) Phase 2 (longitudinal clinical evaluation with 40 patients receiving the intervention at baseline, 2 months, 4 months, and 6 months). The study's primary outcome is asthma control.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ASTHMA-Educator arm | Experimental | The ASTHMA-Educator mobile application for patient-centered asthma education. The application is administered via on-site iPad (tablet). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ASTHMA-Educator mobile application | Other | The on-site delivered ASTHMA-Educator mobile application. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline asthma control to 2, 4, and 6 months | Asthma symptom burden as measured by the Asthma Control Test | Baseline, 2 months, 4 months, 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline asthma knowledge to immediately post-intervention, 2 months, 4 months, and 6 months | Asthma knowledge as measured by the validated Asthma Knowledge Questionnaire | Baseline, immediately post-intervention, 2 months, 4 months, 6 months |
| Patient satisfaction measured by the Client Satisfaction Questionnaire-8 |
Not provided
Inclusion Criteria: Adults (>18 years) with: (a) severe asthma (i.e. at least one asthma-related ED visit and/or hospitalization in the previous year); (b) access to a smartphone with short message service (SMS) capability; (c) English speaking; (d) able to give informed consent.
Exclusion Criteria: (a) use of oral corticosteroids in the 2 weeks prior to the baseline visit; (b) pregnancy; (c) severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol; and (d) patients that previously received the ASTHMAXcel application.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sunit Jariwala | Montefiore Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 | United States |
The investigators will share de-identified and aggregated study findings.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
This is a single-arm proof of concept study to evaluate the impact of the ASTHMA-Educator on process and clinical outcomes
Not provided
Not provided
Not provided
Not provided
Patient satisfaction measured by the Client Satisfaction Questionnaire-8 |
| Immediately post-intervention at the baseline visit, 2 months, 4 months, 6 months |
| Time spent in using the mobile application | Time spent in using the mobile application | Immediately post-intervention at the baseline visit |
| Asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ) | Patients' asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ) | Baseline, 2 months, 4 months, 6 months |
| Asthma emergency department visits | Asthma emergency department visits | Baseline, 2 months, 4 months, 6 months |
| Asthma hospitalizations | Asthma hospitalizations | Baseline, 2 months, 4 months, 6 months |
| Asthma-related steroid courses | Asthma-related steroid courses | Baseline, 2 months, 4 months, 6 months |
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |